What is the recommended dose of Levaquin (levofloxacin) for treating infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin (Levaquin) Dosing Recommendations

The standard recommended dose of levofloxacin for adults with normal renal function is 500 mg once daily for most infections, with a higher dose of 750 mg once daily for severe infections, and a lower dose of 250 mg once daily for uncomplicated urinary tract infections. 1

Adult Dosing by Infection Type

Standard Infections (500 mg once daily)

  • Community-acquired pneumonia (7-14 days)
  • Acute bacterial sinusitis (10-14 days)
  • Acute bacterial exacerbation of chronic bronchitis
  • Complicated urinary tract infections (7-10 days)
  • Acute pyelonephritis

Severe Infections (750 mg once daily)

  • Nosocomial pneumonia
  • Complicated skin and skin structure infections (7-14 days)
  • Community-acquired pneumonia (5 days with high-dose, short-course regimen)

Uncomplicated Infections (250 mg once daily)

  • Uncomplicated urinary tract infections (3 days)

Pediatric Dosing

  • Levofloxacin is generally not recommended for children and adolescents under 18 years due to concerns about effects on bone and cartilage growth 2
  • When benefits outweigh risks (such as in drug-resistant tuberculosis), children may receive levofloxacin at doses of:
    • 16 mg/kg/day divided every 12 hours (not to exceed 250 mg per dose) 2

Renal Dosage Adjustments

For patients with impaired renal function, dose adjustment is necessary:

Creatinine Clearance Dosage Adjustment
≥50 mL/min No adjustment needed
20-49 mL/min Initial dose: 500 mg, then 250 mg every 24 hours
10-19 mL/min Initial dose: 500 mg, then 250 mg every 48 hours
Hemodialysis No supplemental doses needed after dialysis [2]

Administration Considerations

  • Can be taken with or without food 1
  • Must be taken at least 2 hours before or 2 hours after antacids, sucralfate, metal cations (iron), or multivitamins with zinc 1
  • Ensure adequate hydration to prevent crystalluria 1

Special Populations

  • Pregnant women: Should be avoided in pregnancy due to potential teratogenic effects 2
  • Multiple sclerosis patients: Should be avoided due to potential neurological adverse effects that could exacerbate MS symptoms 3

Clinical Pearls and Pitfalls

  • The high-dose, short-course regimen (750 mg for 5 days) maximizes concentration-dependent bactericidal activity and may reduce the potential for resistance development 4
  • Levofloxacin has excellent bioavailability (approaching 100%), allowing for easy transition between IV and oral formulations 5
  • Common adverse effects include nausea and diarrhea; neurologic effects (dizziness, insomnia, tremulousness, headache) occur in approximately 0.5% of patients 2, 3
  • Levofloxacin has a lower photosensitizing potential compared to some other fluoroquinolones 6

Antimicrobial Considerations

  • Levofloxacin demonstrates broad-spectrum activity against Gram-positive and Gram-negative bacteria, including penicillin-resistant Streptococcus pneumoniae 6
  • For urinary tract infections, levofloxacin achieves high urinary concentrations after a 250 mg oral dose, exceeding the MIC90 for typical uropathogens 7
  • When treating tuberculosis, levofloxacin is considered a second-line agent when first-line agents cannot be used due to resistance or intolerance 2

Always consider local antimicrobial resistance patterns when selecting levofloxacin for empiric therapy, as resistance rates may vary by region and infection type.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Use in Multiple Sclerosis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The clinical pharmacokinetics of levofloxacin.

Clinical pharmacokinetics, 1997

Research

[Role of levofloxacin in the treatment of urinary tract infections].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.